Select Committee on Constitutional Affairs Minutes of Evidence


Examination of Witnesses (Questions 80-88)

ANNA ROWLAND, DAVID MARSHALL, RICHARD LANGTON AND TONY GOFF

13 DECEMBER 2005

  Q80  David Howarth: I will ask you to elaborate on that point, if you might. What is the nature of the insurers' interest?

  Tony Goff: That is another issue altogether. The insurance industry appears to have an agenda to change the way in which personal injury claims are handled. They have had that for some time, and I think creating the myth, the perception, shall we say, that there is a compensation culture has suited their purpose, insofar as it has helped them in their arguments, with regard to small claims and other issues. I think they have used it very successfully.

  Richard Langton: There is a widespread belief in the claimant side that insurers have been writing premiums that are too low to get market share for many years, that they have taken on the wrong risk or have been unlucky with natural disasters, things like the asbestosis claims that have come out they were not expecting. The number of insurers has reduced over the last 10 years, there has been a lot of price competition in order to gain market share and now perhaps they are looking at ways in which they can recoup some of the losses; they were hit by the stock market crash, perhaps they underreserved for the risks involved. That is the claimants' perception and now this is a golden opportunity perhaps to get back into profitability.

  Q81  David Howarth: What you are saying is that if there is a sudden, unexpected reduction in the scope of liability they get a windfall?

  Richard Langton: The experience in Australia was that when the tort law reform stopped people pursuing claims insurance premiums did not go down, and I think we are sceptical as to whether there will be a direct cause and effect of, say, increasing the small claims limit and reduction in premiums.

  David Marshall: Certainly the DWP ELCI review did not really find a very close correlation between underwriting costs and premiums, and this idea that, in fact, policies were being underpriced to get market share, it may well be that is a way of recouping, if you can reduce the number of claims. I think that the media side of it and the power of anecdote, it is good stories to read in the press, it is like urban myths being carried forward and often they are very entertaining stories, but when you actually scratch the surface of them . . . I think I was called in once by Sky to talk about backstroke was going to be banned at a local swimming baths because of a risk of injury. I was about to go in, on the seven o'clock news on Sky, to talk about this, and, to their credit, they looked into the story and discovered it was nothing to do with that. Somebody was splashing other people in the pool and it was just a question of trying to stop overexuberant backstroke, nothing to do with compensation culture at all, but that was what they had believed when it was first said. It is good stories and I suppose it sells newspapers.

  Q82  David Howarth: It has been suggested that, instead of the existing court case system, there should be an ombudsman-type, inquisitorial system for smaller claims, funded by the insurance industry. I was just wondering what your view was of that suggestion?

  Tony Goff: This is similar to the Irish system (PIPA).

  Richard Langton: Our experience so far of the Irish system is that a lot of claims have gone into it but we are told very few yet have come out and perhaps when some do we will have some evidence as to how it works. It seems difficult to believe that an efficient lawyer, doing sufficient work on a case, in terms of taking instructions from a client, gathering the necessary evidence to prove a claim, putting in a letter which the insurers accept, in fact is going to do more work than an ombudsman or an administrative bureaucracy; this is just a way of shifting the cost to the ombudsman from the law firm.

  David Marshall: I think the experience of dealing with MIB and CICA, which are very similar sorts of schemes, MIB untraced cases, is it does not speed things up, in fact they are very, very slow and bureaucratic. I think there is an issue of public confidence really, because you talk about the insurer of the wrongdoer and I think the lawyer does add that, that public confidence.

  Q83  Barbara Keeley: Turning to the NHS Redress Bill now, obviously the Bill itself does not provide details of the scheme. Have you received any contact from the Department of Health explaining how it envisages solicitors acting under the new dispute resolution process which will be introduced by the Bill?

  Anna Rowland: We have not had any contact from the Department of Health. We have written to them very recently seeking a meeting to talk through some of the practical details about how the redress scheme might work, but that is quite recent so we have not got to a point of setting a date yet, or anything.

  Richard Langton: We are seeking material though.

  Q84  Barbara Keeley: Do you foresee difficulties currently in drafting, management or enforcement of guaranteed care contracts?

  Richard Langton: No.

  Barbara Keeley: Clearly it has not got that far yet.

  Chairman: Do you think it is a problem?

  Q85  Barbara Keeley: In terms of guaranteed care contracts introduced under the Bill, do you foresee difficulties in drafting those, managing those or enforcing those?

  Anna Rowland: We have not got to that level of detail.

  Q86  Barbara Keeley: A further question is around really the provision of independent medical reports. I think The Law Society have touched on this in your written evidence to us for today. What practical difficulties do you envisage if solicitors are not provided with that independent medical report but are still asked to advise clients on whether to settle the claim out of court?

  Anna Rowland: I think two issues arise. As you rightly say, there is the issue of independence, which is to do with consumer confidence. I heard a minister speak recently and say that independence would be guaranteed by the fact that the NHSLA would be involved. Certainly our view is that if the redress claim does not work and the claimant goes to court the NHSLA will then be representing the person on the other side. Clearly, there is an issue of consumer confidence there. The second issue is about how the role of the lawyer and independent advice will work, which is connected to that, to the extent that it depends at what stage the lawyer gets involved. We do perceive some practical difficulties if what is envisaged is that presumably there is an internal investigation and then an offer is made and the claimant is simply sent along to a lawyer. What the lawyer will not know is was there other information that has not been considered, has all the information been considered, so what are the difficulties, and what you do not really want happening then is the lawyer having to reinvestigate just in order to advise the client. Clearly, the issue of how independent are the documents they are seeing will be a factor, but we think there is a further factor about how does a lawyer, also from the terms of their own duty to give best advice to the client, say "Yes, this is good," or not, if they do not know whether they are seeing the full picture or not. I think what we would like to discuss at the Department of Health is how that relationship might work and how you ensure that the lawyer has enough information to say to the claimant, "Well, this is the ballpark of what I think you should get; this looks fair," or "this does not." I think that needs a little more thought, although we accept that you are going to want their involvement to be more streamlined than it is at present, in most cases.

  Q87  Barbara Keeley: Clearly, the aim is to avoid introducing undue costs into the scheme, clearly that is an overall aim. Is there a way, do you think, to allow for independent verification of settlements, it is a balance, is it not, costs on one side and independent verification on the other side?

  Anna Rowland: I do not see why it should be impossible to do that. I think the details need some further thought. I think that is something we will want to discuss in greater detail. I do not see why that should be impossible but, we have very little detail. Just saying, "Oh, you can then go along for some advice" there are difficulties with that. Certainly we would think it must be possible to create a streamlined system, but it needs some thought.

  David Marshall: I think it is important that the public feel there is sufficient rigour and independence in the investigation, and certainly various attempts to revamp NHS complaint regimes have not really commanded a great deal of confidence. There are lots of shades of grey in medical practice and I think it would be very, very disappointing if the redress scheme, which I think does have lots of potential advantages in bringing a cheaper system for the smaller cases, were to fail because there was not really the idea that there was a publicly accountable way of investigating the NHS. I think the lawyer does have a very important role, and you cannot just say, "Here's our report, carried out internally, is it any good?" I just do not see how a lawyer can possibly deal with that sort of situation.

  Richard Langton: There may even be some benefit in a lawyer at the earlier stages giving independent advice to the patient that this is a good scheme that they can trust to go through, even if the lawyer's initial involvement is relatively modest, and perhaps identifies maybe evidence that needs to be saved, just in case, at the end of this scheme, which is still going to be fault-based, the claim is rejected. In terms of consumer confidence, or the patient confidence, in the system, having an independent person there at the beginning may well assist in ensuring that this works.

  Q88  Barbara Keeley: My final question was going to be do you think such a scheme could operate fairly without input by lawyers, but I think you have answered that. You see it coming in at a couple of points?

  David Marshall: Yes.

  Chairman: Thank you very much indeed for giving us the benefit of your experience. Clearly there are further meetings we are going to have to have with the Department in order for them to answer some of the questions we were putting today. Thank you very much.





 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2006
Prepared 10 March 2006